Breast Cancer Clinical Trial

Exercise Treatment With Standard Therapy for Metastatic Breast Cancer

Summary

This study will test any good and bad effects of aerobic exercise performed while you are receiving the usual first-line treatment for metastatic breast cancer. The researchers think that exercise helps delay the development of resistance to hormone therapy while slowing the growth of tumors.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with histologically-confirmed, HR-positive (ER and/or PR), HER2-negative metastatic breast cancer (MBC)
Postmenopausal status defined by lack of menses for 2 years, oophorectomy, or medical ovarian suppression
Receiving first line endocrine-based therapy (tamoxifen, aromatase inhibitor, or fulvestrant; concurrent molecular therapy also allowed)
Sedentary (i.e., <60 minutes > Age >18 years
BMI ≥ 18.5
Cleared for exercise participation as per screening clearance via PAR-Q+
Cleared for study participation as per screening consultation with an MSK Exercise Physiologist
Willingness to comply with all study-related procedures
Patients with "treated and stable" brain lesions of a duration of ≥ 2 months may be enrolled

Exclusion Criteria:

Life expectancy <6 months
Enrollment onto any other therapeutic investigational study
Mental impairment leading to inability to cooperate
Concurrent participation in weight loss or other exercise programs

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

53

Study ID:

NCT03988595

Recruitment Status:

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 8 Locations for this study

See Locations Near You

Memoral Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge New Jersey, 07920, United States More Info
Neil Iyengar, MD
Contact
646-888-4714
Memoral Sloan Kettering Monmouth (Limited Protocol Activities)
Middletown New Jersey, 07748, United States More Info
Neil Iyengar, MD
Contact
646-888-4714
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale New Jersey, 07645, United States More Info
Neil Iyengar, MD
Contact
646-888-4714
Montefiore Health Systems (Montefiore Medical Center) (Data Collection Only)
Bronx New York, 10467, United States More Info
Jesus Anampa Mesias, MD
Contact
866-633-8255
Memorial Sloan Kettering Cancer Center @ Suffolk (Limited protocol activity)
Commack New York, 11725, United States More Info
Neil Iyengar, MD
Contact
646-888-4714
Memoral Sloan Kettering Westchester (Limited Protocol Activities)
Harrison New York, 10604, United States More Info
Neil Iyengar, MD
Contact
646-888-4714
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States More Info
Neil Iyengar, MD
Contact
646-888-4714
Lee Jones, PhD
Contact
646-888-8103
Neil Iyengar, MD
Principal Investigator
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
Uniondale New York, 11553, United States More Info
Neil Iyengar, MD
Contact
646-888-4714

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

53

Study ID:

NCT03988595

Recruitment Status:

Recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.